Wider indications for treatment with biosynthetic human growth hormone in children. 1991

P C Hindmarsh, and N A Bridges, and C G Brook
Endocrine Unit, Middlesex Hospital, London, UK.

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011628 Puberty, Delayed The lack of development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations above the mean age at onset of PUBERTY in a population. Delayed puberty can be classified by defects in the hypothalamic LHRH pulse generator, the PITUITARY GLAND, or the GONADS. These patients will undergo spontaneous but delayed puberty whereas patients with SEXUAL INFANTILISM will not. Delayed Puberty
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004992 Ethics, Medical The principles of professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families. Medical Ethics
D005260 Female Females
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone

Related Publications

P C Hindmarsh, and N A Bridges, and C G Brook
January 1991, Clinical pediatrics,
P C Hindmarsh, and N A Bridges, and C G Brook
January 1987, Srpski arhiv za celokupno lekarstvo,
P C Hindmarsh, and N A Bridges, and C G Brook
September 1997, Presse medicale (Paris, France : 1983),
P C Hindmarsh, and N A Bridges, and C G Brook
May 1990, The Journal of endocrinology,
P C Hindmarsh, and N A Bridges, and C G Brook
March 1990, Irish medical journal,
P C Hindmarsh, and N A Bridges, and C G Brook
January 1995, Clinical endocrinology,
P C Hindmarsh, and N A Bridges, and C G Brook
January 1990, Acta paediatrica Scandinavica. Supplement,
P C Hindmarsh, and N A Bridges, and C G Brook
February 1993, Boletin medico del Hospital Infantil de Mexico,
P C Hindmarsh, and N A Bridges, and C G Brook
January 1991, Hormone research,
P C Hindmarsh, and N A Bridges, and C G Brook
September 1988, Anales espanoles de pediatria,
Copied contents to your clipboard!